Detalles de la búsqueda
1.
MASH Resolution Index: development and validation of a non-invasive score to detect histological resolution of MASH.
Gut
; 2024 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38418210
2.
Development and Validation of the Nonalcoholic Fatty Liver Disease Familial Risk Score to Detect Advanced Fibrosis: A Prospective, Multicenter Study.
Clin Gastroenterol Hepatol
; 22(1): 81-90.e4, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37406954
3.
Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study.
Gastroenterology
; 165(2): 463-472.e5, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37127100
4.
Hepatocellular Carcinoma Incidence in Alcohol-Associated Cirrhosis: Systematic Review and Meta-analysis.
Clin Gastroenterol Hepatol
; 21(5): 1169-1177, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35940513
5.
Docosahexaenoic Acid Levels and Omega-3 Index, but Not Eicosapentaenoic Acid Levels, Are Associated With Improved Cognition in Cognitively Healthy Subjects With Coronary Artery Disease.
Arterioscler Thromb Vasc Biol
; 43(2): 382-384, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36579646
6.
Clinical Utility of Combined MRI-PDFF and ALT Response in Predicting Histologic Response in Nonalcoholic Fatty Liver Disease.
Clin Gastroenterol Hepatol
; 21(10): 2682-2685.e4, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36075503
7.
Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality.
Aliment Pharmacol Ther
; 59(1): 80-88, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37968251
8.
Review article: the role of HSD17B13 on global epidemiology, natural history, pathogenesis and treatment of NAFLD.
Aliment Pharmacol Ther
; 57(1): 37-51, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36349732
9.
Regression of Coronary Fatty Plaque and Risk of Cardiac Events According to Blood Pressure Status: Data From a Randomized Trial of Eicosapentaenoic Acid and Docosahexaenoic Acid in Patients With Coronary Artery Disease.
J Am Heart Assoc
; 12(18): e030071, 2023 09 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37681568
10.
Clinical utility of liver fat quantification for determining cardiovascular disease risk among patients with type 2 diabetes.
Aliment Pharmacol Ther
; 58(6): 585-592, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37431679
11.
Eicosapentaenoic and docosahexaenoic acid supplementation and coronary artery calcium progression in patients with coronary artery disease: A secondary analysis of a randomized trial.
Atherosclerosis
; 387: 117388, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38056242
12.
Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis.
Lancet Gastroenterol Hepatol
; 8(9): 829-836, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37419133
13.
Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Adv Ther
; 40(11): 4805-4816, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37615850
14.
Comprehensive Review of Cardiovascular Complications of Coronavirus Disease 2019 and Beneficial Treatments.
Cardiol Rev
; 30(3): 145-157, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35384908
15.
ω-3 Ethyl ester results in better cognitive function at 12 and 30 months than control in cognitively healthy subjects with coronary artery disease: a secondary analysis of a randomized clinical trial.
Am J Clin Nutr
; 113(5): 1168-1176, 2021 05 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33675344
Resultados
1 -
15
de 15
1
Próxima >
>>